3 June 2024
Brain Sciences | Highly Cited Papers in 2022–2023 in the Section “Neuropharmacology and Neuropathology”


The “Neuropharmacology and Neuropathology” Section of the journal Brain Sciences (ISSN: 2076-3425) aims to present findings within the neuropharmacology and neuropathology field from mechanistic insights to putative therapeutic strategies.

As all of the articles published in our journal are of an open access format, you have free and unlimited access to the full texts. We welcome you to read our most highly cited papers published in 2022 and 2023 listed below:

1. “Biomarkers in Neuropsychiatric Systemic Lupus Erythematosus: A Systematic Literature Review of the Last Decade”
by Julius Lindblom, Chandra Mohan and Ioannis Parodis
Brain Sci. 2022, 12(2), 192; https://doi.org/10.3390/brainsci12020192
Available online: https://www.mdpi.com/2076-3425/12/2/192

2. “Pharmacological Treatments for Cocaine Craving: What Is the Way Forward? A Systematic Review”
by Dângela Layne Silva Lassi, André Malbergier, André Brooking Negrão, Lígia Florio, João P. De Aquino and João Maurício Castaldelli-Maia
Brain Sci. 2022, 12(11), 1546; https://doi.org/10.3390/brainsci12111546
Available online: https://www.mdpi.com/2076-3425/12/11/1546

3. “Acute Cerebellar Inflammation and Related Ataxia: Mechanisms and Pathophysiology”
by Md. Sorwer Alam Parvez and Gen Ohtsuki
Brain Sci. 2022, 12(3), 367; https://doi.org/10.3390/brainsci12030367
Available online: https://www.mdpi.com/2076-3425/12/3/367

4. “Keeping the Balance: GABAB Receptors in the Developing Brain and Beyond”
by Davide Bassetti
Brain Sci. 2022, 12(4), 419; https://doi.org/10.3390/brainsci12040419
Available online: https://www.mdpi.com/2076-3425/12/4/419

5. “Kappa Free Light Chains in Cerebrospinal Fluid in Inflammatory and Non-Inflammatory Neurological Diseases”
by Franz Felix Konen, Philipp Schwenkenbecher, Konstantin Fritz Jendretzky, Stefan Gingele, Torsten Witte, Kurt-Wolfram Sühs, Matthias Grothe, Malte Johannes Hannich, Marie Süße and Thomas Skripuletz
Brain Sci. 2022, 12(4), 475; https://doi.org/10.3390/brainsci12040475
Available online: https://www.mdpi.com/2076-3425/12/4/475

6. “Therapeutic Strategies to Ameliorate Neuronal Damage in Epilepsy by Regulating Oxidative Stress, Mitochondrial Dysfunction, and Neuroinflammation”
by Sahithi Madireddy and Samskruthi Madireddy
Brain Sci. 2023, 13(5), 784; https://doi.org/10.3390/brainsci13050784
Available online: https://www.mdpi.com/2076-3425/13/5/784

7. “A Comprehensive Review on Anti-Inflammatory Response of Flavonoids in Experimentally-Induced Epileptic Seizures”
by Shyam Sunder Rabidas, Chandra Prakash, Jyoti Tyagi, Jyoti Suryavanshi, Pavan Kumar, Jaydeep Bhattacharya and Deepak Sharma
Brain Sci. 2023, 13(1), 102; https://doi.org/10.3390/brainsci13010102
Available online: https://www.mdpi.com/2076-3425/13/1/102

8. “Characteristics of Movement Disorders in Patients with Autoimmune GFAP Astrocytopathy”
by Akio Kimura, Akira Takekoshi and Takayoshi Shimohata
Brain Sci. 2022, 12(4), 462; https://doi.org/10.3390/brainsci12040462
Available online: https://www.mdpi.com/2076-3425/12/4/462

9. “Neuropsychiatric Manifestations of Antiphospholipid Syndrome—A Narrative Review”
by Yik Long Man and Giovanni Sanna
Brain Sci. 2022, 12(1), 91; https://doi.org/10.3390/brainsci12010091
Available online: https://www.mdpi.com/2076-3425/12/1/91

10. “Mood Stabilizers of First and Second Generation”
by Janusz K. Rybakowski
Brain Sci. 2023, 13(5), 741; https://doi.org/10.3390/brainsci13050741
Available online: https://www.mdpi.com/2076-3425/13/5/741

Back to TopTop